- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | XFRA NEW INSTRUMENTS AVAILABLE ON 27.11.2025 | 250 | Xetra Newsboard | The following instruments on XETRA do have their first trading 27.11.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 27.11.2025
Aktien
1 CNE100003KK7 Rizhao Port Jurong Co.... ► Artikel lesen | |
| PREVECEUTICAL MEDICAL Aktie jetzt für 0€ handeln | |||||
| 26.11. | Preveceutical Medical Inc: Preveceutical, BioGene complete plan of arrangement | 1 | Stockwatch | ||
| 26.11. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 26.11.2025 | 773 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 26.11.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 26.11.2025ISIN NameCA74141E1043 PREVECEUTICAL... ► Artikel lesen | |
| 26.11. | XFRA ISIN CHANGE | 431 | Xetra Newsboard | Einstellung Aufnahme ISIN Name CCP bis Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenAU000000VG15 Regal Partners Global Investments Ltd. 26.11.2025 AU0000434920 Regal Partners Global Investments... ► Artikel lesen | |
| 26.11. | PreveCeutical Medical Inc.: PreveCeutical Medical and BioGene Therapeutics Announce Closing of Plan of Arrangement | 182 | Newsfile | NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVancouver, British Columbia--(Newsfile Corp. - November 26, 2025) - PreveCeutical Medical Inc. (CSE:... ► Artikel lesen | |
| 25.11. | XFRA 18H: AUSSETZUNG/SUSPENSION | 98 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILPREVECEUTICAL MED.... ► Artikel lesen | |
| 24.11. | Preveceutical Medical Inc: Preveceutical Medical distribution, reclassification | 2 | Stockwatch | ||
| 24.11. | CSE Bulletin: Notice of Distribution and Reclassification - PreveCeutical Medical Inc. (PREV) | 248 | Newsfile | Toronto, Ontario--(Newsfile Corp. - Le 24 novembre/November 2025) - PreveCeutical Medical Inc. ("PreveCeutical") has announced the effective date of the reclassification as well as the previously... ► Artikel lesen | |
| 20.11. | Preveceutical Medical Inc: Preveceutical to close BioGene deal effective Nov. 24 | 2 | Stockwatch | ||
| 20.11. | PreveCeutical Medical Inc.: PreveCeutical Provides Clarification of News Release Announcing Update on Plan of Arrangement with BioGene Therapeutics Inc. | 313 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - November 20, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that, further to its... ► Artikel lesen | |
| 20.11. | PreveCeutical Medical Inc.: PreveCeutical Provides Update on Plan of Arrangement with BioGene Therapeutics Inc. | 175 | Newsfile | NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVancouver, British Columbia--(Newsfile Corp. - November 20, 2025) - PreveCeutical Medical Inc. (CSE:... ► Artikel lesen | |
| 30.10. | Preveceutical Medical Inc: Preveceutical closes $455k second tranche of placement | 2 | Stockwatch | ||
| 20.10. | PreveCeutical Medical Inc.: PreveCeutical Provides Update on Plan of Arrangement with BioGene Therapeutics Inc. | 257 | Newsfile | NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVancouver, British Columbia--(Newsfile Corp. - October 20, 2025) - PreveCeutical Medical Inc. (CSE:... ► Artikel lesen | |
| 13.10. | PreveCeutical Medical boosts private placement to $1.2M, following shareholder meeting approvals | 4 | Seeking Alpha | ||
| 11.10. | Preveceutical Medical Inc: Preveceutical hikes placement, releases AGSM results | 4 | Stockwatch | ||
| 10.10. | PreveCeutical Medical Inc.: PreveCeutical Announces Results from Annual General and Special Meeting and Increase to Size of Non-Brokered Private Placement | 402 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - October 10, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that all... ► Artikel lesen | |
| 20.09. | Preveceutical Medical Inc: Preveceutical mails documents for Oct. 10 AGM | 4 | Stockwatch | ||
| 20.09. | PreveCeutical Medical Inc.: PreveCeutical Announces Mailing and Filing of Annual General and Special Meeting Materials in Connection with a Proposed Arrangement with BioGene Therapeutics | 878 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - September 19, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that further to its... ► Artikel lesen | |
| 06.09. | Preveceutical Medical Inc: Preveceutical closes $646,500 tranche one of placement | 4 | Stockwatch | ||
| 05.09. | PreveCeutical Medical Inc.: PreveCeutical Closes Initial Tranche of Non-Brokered Private Placement | 846 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - September 5, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that... ► Artikel lesen |
1 2 3 Weiter >>
53 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 47,010 | +0,32 % | DZ BANK stuft Fresenius SE auf 'Kaufen' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Aktienwert für Fresenius nach den Anfang November vorgelegten Zahlen zum dritten Quartal von 56 auf 57 Euro angehoben. Die Einstufung wurde... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,410 | -1,20 % | UBS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Sell' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für FMC mit einem Kursziel von 38 Euro auf "Sell" belassen. Analyst Graham Doyle blieb in seiner Einschätzung vom Freitagabend... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 42,540 | +0,05 % | PRESSESPIEGEL/Unternehmen: SIEMENS HEALTHINEERS, INSTONE, BÖRSE STUTTGART, VOLKSWAGEN | DJ PRESSESPIEGEL/Unternehmen
Die wirtschaftsrelevanten Themen aus den Medien, zusammengestellt von Dow Jones Newswires.
SIEMENS HEALTHINEERS - Das größte Potenzial sieht Siemens-Healthineers-CEO... ► Artikel lesen | |
| DRAEGERWERK | 67,80 | -1,74 % | EQS-News: Drägerwerk AG & Co. KGaA: Bekanntmachung nach Art. 5 Abs. 1 und Abs. 3 der Verordnung (EU) Nr. 596/2014: Erwerb eigener Aktien - Abschlussmeldung | EQS-News: Drägerwerk AG & Co. KGaA
/ Schlagwort(e): Sonstiges
Drägerwerk AG & Co. KGaA: Bekanntmachung nach Art. 5 Abs. 1 und Abs. 3 der Verordnung (EU) Nr. 596/2014: Erwerb eigener... ► Artikel lesen | |
| MEDTRONIC | 87,58 | -0,23 % | Medtronic Launches MiniMed 780G In U.S. With Abbott's New Instinct CGM Sensor | DUBLIN (dpa-AFX) - Medtronic (MDT) has begun the full U.S. rollout of the MiniMed 780G insulin delivery system integrated with Abbott's Instinct sensor, following FDA clearance earlier this... ► Artikel lesen | |
| INTUITIVE SURGICAL | 485,80 | -0,54 % | Is Intuitive Surgical's Dominance Safe? 10 Years of Healthcare Upside | ||
| TELADOC HEALTH | 6,424 | -0,63 % | Teladoc Health, Inc.: Teladoc Health Announces Chief Financial Officer Transition | NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced that Mala Murthy will be stepping down from her role as Chief Financial... ► Artikel lesen | |
| THERMO FISHER | 500,80 | +0,32 % | Thermo Fisher Scientific deepens investment in Asia's biopharma ecosystem | ||
| SERNOVA BIOTHERAPEUTICS | 0,088 | +0,57 % | Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 13, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH) ("Sernova or the Company)") a leading regenerative medicine... ► Artikel lesen | |
| FAMICORD | 5,350 | -0,93 % | EQS-News: FamiCord AG beschleunigt profitables Wachstum im dritten Quartal 2025 und stärkt Qualität und Visibilität der Umsatzentwicklung | EQS-News: FamiCord AG
/ Schlagwort(e): 9-Monatszahlen
FamiCord AG beschleunigt profitables Wachstum im dritten Quartal 2025 und stärkt Qualität und Visibilität der Umsatzentwicklung... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 35,140 | 0,00 % | BMO Capital Maintains Bullish 12%+ BrightSpring EBITDA Growth Outlook on Drug Contract Wins, Generic Conversions | ||
| ALIGNMENT HEALTHCARE | 19,090 | 0,00 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| GENEDX | 160,60 | 0,00 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 29,530 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,000 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen |
Das Unternehmen PREVECEUTICAL MEDICAL INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +2,73 % bei einem Aktienkurs von 0,011 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PREVECEUTICAL MEDICAL INC finden Sie auf Wallstreet Online.